M
Marianne Nicolson
Researcher at Aberdeen Royal Infirmary
Publications - 60
Citations - 4500
Marianne Nicolson is an academic researcher from Aberdeen Royal Infirmary. The author has contributed to research in topics: Lung cancer & Pemetrexed. The author has an hindex of 30, co-authored 60 publications receiving 3919 citations.
Papers
More filters
Journal ArticleDOI
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Martyn Caplin,Eric Baudin,Piero Ferolla,P.L. Filosso,Mariano García-Yuste,Eric Lim,Kjell Öberg,Giuseppe Pelosi,Aurel Perren,Roberta Elisa Rossi,Roberta Elisa Rossi,William D. Travis,Detlief Bartsch,Jaume Capdevila,Frederico Costa,Jarosław B. Ćwikła,Wouter W. de Herder,Gianfranco Delle Fave,Barbro Eriksson,Massimo Falconi,Diego Ferone,David J. Gross,Ashley B. Grossman,Tetsuhide Ito,Robert T. Jensen,Gregory Kaltsas,Fahrettin Kelestimur,Reza Kianmanesh,Ulrich Knigge,Beata Kos-Kudła,Eric P. Krenning,Emmanuel Mitry,Marianne Nicolson,Juan Manuel O'Connor,Dermot O'Toole,Ulrich Frank Pape,Marianne Pavel,John Ramage,Eric Raymond,Guido Rindi,Andrea Rockall,Philippe Ruszniewski,Ramon Salazar,Aldo Scarpa,Eva Sedlackova,Anders Sundin,Christos Toumpanakis,Marie Pierre Vullierme,Wolfgang Weber,Bertram Wiedenmann,Zeng Zheng-Pei +50 more
TL;DR: PCs are complex tumors which require a multidisciplinary approach and long-term follow-up, and may be considered as first-line systemic antiproliferative treatment in unresectable PCs, particularly of low-grade TC and AC.
Journal ArticleDOI
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
Johan Vansteenkiste,L. Crinò,Christophe Dooms,Jean-Yves Douillard,Corinne Faivre-Finn,Eric Lim,Gaetano Rocco,Suresh Senan,P. Van Schil,Giulia Veronesi,R. Stahel,Solange Peters,Enriqueta Felip,Keith M. Kerr,Benjamin Besse,Wilfried Eberhardt,Martin J. Edelman,Tony Mok,Kenneth J. O'Byrne,Silvia Novello,Lukas Bubendorf,Antonio Marchetti,Paul Baas,Martin Reck,Konstantinos N. Syrigos,Luis Paz-Ares,Egbert F. Smit,Peter Meldgaard,Alex A. Adjei,Marianne Nicolson,Walter Weder,Dirk De Ruysscher,Cécile Le Péchoux,Paul De Leyn,Virginie Westeel +34 more
TL;DR: A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-stage disease and locally advanced disease.
Journal ArticleDOI
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
W. Eberhardt,Dirk De Ruysscher,W. Weder,C. Le Pechoux,P. De Leyn,Hans Hoffmann,V. Westeel,Rolf A. Stahel,E. Felip,S. Peters,Rolf A. Stahel,Enriqueta Felip,Solange Peters,Keith M. Kerr,Benjamin Besse,Johan Vansteenkiste,Wilfried Eberhardt,Martin J. Edelman,Tony Mok,Kenneth J. O'Byrne,Silvia Novello,Lukas Bubendorf,Antonio Marchetti,Paul Baas,Martin Reck,Konstantinos N. Syrigos,Luis Paz-Ares,Egbert F. Smit,Peter Meldgaard,Alex A. Adjei,Marianne Nicolson,Lucio Crinò,Paul Van Schil,Suresh Senan,Corinne Faivre-Finn,Gaetano Rocco,Giulia Veronesi,Jean-Yves Douillard,Eric Lim,Christophe Dooms,Walter Weder,Dirk De Ruysscher,Cécile Le Péchoux,Paul De Leyn,Virginie Westeel +44 more
TL;DR: A total of 35 experts met to address several questions on non-small-cell lung cancer in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease.
Journal ArticleDOI
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton,Paul Silcocks,Trevor Cox,Juan W. Valle,Jonathan Wadsley,David Propper,Fareeda Y. Coxon,Paul Ross,Srinivasan Madhusudan,Tom Roques,David Cunningham,Stephen Falk,Nick Wadd,Mark Harrison,Pippa Corrie,Timothy Iveson,A. Robinson,Karen McAdam,Martin Eatock,Jeff Evans,Caroline Archer,Tamas Hickish,Angel Garcia-Alonso,Marianne Nicolson,W.P. Steward,Alan Anthoney,William Greenhalf,Victoria Shaw,Eithne Costello,Dean J. Naisbitt,Charlotte L. Rawcliffe,Gemma Nanson,John P. Neoptolemos +32 more
TL;DR: Adding GV1001 vaccination to chemotherapy did not improve overall survival and new strategies to enhance the immune response effect of telomerase vaccination were not found.
Journal ArticleDOI
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
Keith M. Kerr,Lukas Bubendorf,Martin J. Edelman,Antonio Marchetti,Tony Mok,Silvia Novello,Kenneth J. O'Byrne,Kenneth J. O'Byrne,Rolf A. Stahel,Solange Peters,Enriqueta Felip,Benjamin Besse,Johan Vansteenkiste,Wilfried Eberhardt,Paul Baas,Martin Reck,Konstantinos N. Syrigos,Luis Paz-Ares,Egbert F. Smit,Peter Meldgaard,Alex A. Adjei,Marianne Nicolson,Lucio Crinò,Paul Van Schil,Suresh Senan,Corinne Faivre-Finn,Gaetano Rocco,Giulia Veronesi,Jean-Yves Douillard,Eric Lim,Christophe Dooms,Walter Weder,Dirk De Ruysscher,Cécile Le Péchoux,Paul De Leyn,Virginie Westeel +35 more
TL;DR: Recommendations for pathology and molecular biomarkers in relation to the diagnosis of lung cancer, primarily non-small-cell carcinomas are focused on.